Latest posts
-
Argentum 47, Inc. Moves into Online Cloud Business with New SaaS Module
WINDSOR, BERKSHIRE, UK, October 24, 2023 – Argentum 47, Inc. (OTC PINK: ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead generation, today announced that it has developed the Company’s proprietary AI Technology and platforms into a SaaS (Software-as-a-Service) model. Argentum 47 unifies all aspects of Marketing under one roof
-
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
Pittsburgh, PA, October 23, 2023 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th – 27th. Dr. Jonathan Kaufman, CEO of Lipella, said: “2023
-
PRISM MediaWire – Weekly Press Resume – Oct. 16 to Oct. 20, 2023
New York, New York, October 20, 2023 PRISM MediaWire – Weekly Press Resume Oct. 16 to Oct. 20, 2023 BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference POMPANO BEACH, FLORIDA, October 17, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture,
-
Argentum 47 Inc. Ventures into the European Medical Cannabis Industry to Capitalize on the Growing Market
WINDSOR, BERKSHIRE, United Kingdom, October 19, 2023 – Argentum 47, Inc. (“Argentum” or the “Company”)(www.argq.io) (OTC PINK: ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead generation, announced today that it has entered into talks with a European medical cannabis company that is fully integrated with strategic assets along the
-
SinglePoint Inc. Acquires remaining 49% of Box Pure Air LLC, Implements Strategic Restructuring to Enhance Indoor Air Revenue Opportunity with Schools in California, Box Pure Air LLC Now a Wholly Owned Subsidiary
$800,000 in pending orders to fulfill through the $5,000,000 Grant Award Notification (GAN) in California SinglePoint Inc. retains minority interest in Ballistic Product America, LLC (“Ballistic”) Ballistic has entered into an agreement with SinglePoint in which it Ballistic agrees to pay to SinglePoint, as a periodic royalty (“Royalty”), five percent of the gross revenue of
-
Free webinar Desalination Latin America: Progress of Key Projects – Introducing Jose Nicolas De Pierola Canales, Senior Advisor and Consultant at Jose N. De Pierola C. Consulting Engineering at Water Resources.
October 18, 2023 Organizer: Vostock Capital Prior to the 6th International Conference and Exhibition DESALINATION LATIN AMERICA 2024, 13-14 March 2024 Santiago, Chile The desalination webinar will be held on 19th October de 2023 at 10 am (-4 GMT) Santiago de Chile time. The webinar’s language is English. Register to get the webinar material in
-
BioStem Technologies to Present at the Fall Foliage MicroCap Rodeo Conference
POMPANO BEACH, FLORIDA, October 18, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th – 27th. Jason Matuszewski, Chief Executive
-
UA Multimedia Provides Business Update and Upcoming Initiatives
IRVINE, CA, October 18, 2023 – UA Multimedia, Inc. (OTC: UAMM), a technology solution provider specializing in cybersecurity, artificial intelligence (AI) and information technology outsourcing, is pleased to present a business update highlighting recent developments and the upcoming initiatives for the near term. Pascal Software Since acquiring a 12% stake in Pascal Software in Q2,
-
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
POMPANO BEACH, FLORIDA, October 17, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that it will highlight the advantages of its Vendaje® and AmnioWrap2TM portfolios to help patients with difficult to heal chronic wounds at